Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

FFR - Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Company: Lineage Cell Therapeutics Inc. Date: 2025-03-11 Language: English Register to download

Loading document preview...

Document Preview Not Available

The file type (.htm) cannot be displayed directly here.

Open Original File

Error loading document preview. Please try the 'Open Original File' link.

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:

Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon

   

\_\_\_\_\_\_\_\_\_ false

|     |     |
| --- | --- |
| ������' �� ��������� ���� | 2 379 |
| .LINEAGE CELL THERAPEUTICS, INC |
| Corporation no: 876343 | 10834 |
| - - - |
|     |

|     |     |     |     |     |     |     |     |     |     |     |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|     | Israel Securities Authority |     |     | Tel Aviv Stock Exchange |     | C001 ( Public ) |     | Reported via MAGNA: | 11/03/2025 |     |
|     | www.isa.gov.il |     |     | www.tase.co.il |     |     |     | Reference: | 2025-02-016022 | Time of broadcast: 10:21 10:21 |

- - -

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000  

  

|     |     |
| --- | --- |
|     | The corporation is a foreign private issuer as defined by U.S. Securities Laws. |

  

Attached hereto is a report on*Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update*  

*Full\_Year\_2024\_Financial\_Results\_isa.pdf*  

  

Link to filing on foreign stock exchange (optional): \_\_\_\_\_\_\_\_\_

|     |     |
| --- | --- |
|     |     |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): |     |
|     |     |
|     |     |
| - - - |     |
| Stock Exchange/Market: \-1 | Date of revision of form structure: 06/08/2024 |
| Address: HARBOR BAY PARKWAY 1301 , ALAMEDA 94502   CALIFORNIA , U.S.A Tel: 5105213390 , Fax: 5105213389 |     |
| E-mail address: info@biotimeinc.com   Company site: biotimeinc.com |     |
|     |     |
| Previous names of reporting entity: .BIOTIME, INC |     |
|     |     |
| Name of the Signatory: Gerzi SHNEOR Ilan Position of Signatory in the reporting corporation: Legal Adviser Name of Employer Company: PEARL COHEN ZEDEK LATZER BARATZ |     |
| Address: Derech Menachem Begin 121 , Tel Aviv 6701203 Telephone: 03-3039000 Facsimile: E-mail: igerzi@pearlcohen.com 1 |     |
| U.S.A |